$CLOV SEC Filings

Filed On	Filing
20 Oct 2026	Form 4: Soares Karen, Chief Legal Officer Sold 19,275 shares ($89.8K)
20 Oct 2026	Form 4: Reynoso Jamie L., CEO, Medicare Advantage Sold 4,066 shares ($17.9K)
20 Oct 2026	144
19 Oct 2026	Form 4: Toy Andrew, Director Sold 62,176 shares ($291K)
19 Oct 2026	Form 4: Soares Karen, Chief Legal Officer Sold 14,673 shares ($68.7K)
19 Oct 2026	Form 4: Thornton Joseph Clay, Interim CFO Sold 4,591 shares ($21.5K)
19 Oct 2026	Form 4: Wai Conrad, CEO, Counterpart Health Sold 23,627 shares ($111K)
19 Oct 2026	Form 4: Reynoso Jamie L., CEO, Medicare Advantage Sold 18,273 shares ($85.5K)
19 Oct 2026	144
15 Oct 2026	144
15 Oct 2026	144
15 Oct 2026	144
15 Oct 2026	144
15 Oct 2026	144
09 Oct 2026	8-K: Regulation FD Disclosure WILMINGTON, Del., Oct. 8, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that the Centers for Medicare & Medicaid Services (“CMS”) has awarded its PP...
07 Oct 2026	Form 4: Reynoso Jamie L., CEO, Medicare Advantage Sold 2,006 shares ($9.29K)
07 Oct 2026	144
05 Oct 2026	Form 4: Reynoso Jamie L., CEO, Medicare Advantage Sold 8,750 shares ($38.7K)
05 Oct 2026	144
02 Oct 2026	Form 4: Miller Brian James, Director Received 12,481 shares as a grant or award

Comments